Loading...

Follow Children's Cancer Institute on Feedspot

Continue with Google
Continue with Facebook
or

Valid

Our researchers have found a way to dramatically slow neuroblastoma growth, using a combination of drugs that starves cells of essential nutrients called polyamines.

The post Our researchers combine an old drug with a new one to starve neuroblastoma appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Research Assistant Olivia Ciampa recently spent six months working in a collaborator’s lab at the Mayo Clinic, Minnesota, USA. I asked her why she went there, what it was like, and what she achieved.

The post Researcher travels 14,500 km to find better treatments for neuroblastoma appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Groundbreaking research from our Leukaemia Biology Program has revealed how acute lymphoblastic leukaemia can become resistant to a class of anti-cancer drugs called glucocorticoids.

The post Fundamental mechanism behind chemotherapy resistance revealed appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Curing childhood cancer requires global effort. In this new blog series, you’ll meet some of the many national and international partners who are working with us to make it happen. We’ll start with Cancer Therapeutics CRC.

The post Partnerships: Cancer Therapeutics CRC appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Our researchers have developed a method to measure the amount of copper inside neuroblastoma tumours. Published in the journal Theranostics, it offers a potential tool for treating and monitoring neuroblastoma.

The post New imaging method could help treat and monitor neuroblastoma appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Twenty-six police officers and one cancer researcher took to the skies last Sunday to raise funds for childhood cancer research. The inaugural Great Cop Drop was inspired by Isla, a little girl diagnosed with leukaemia four years ago.

The post Great Cop Drop is windfall for childhood cancer research appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

A drug called OBI-3424 has been designated an Orphan Drug by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukaemia, based predominantly on research carried out by our Leukaemia Biology Program.

The post New drug OBI-3424 designated an ‘Orphan Drug’ to treat acute lymphoblastic leukaemia appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Ten of our researchers spent a successful and productive two days at the Sydney Cancer Conference at Darling Harbour last week. The work they presented was very well-received, with two speakers carrying off prizes.

The post Our researchers make a splash at the Sydney Cancer Conference appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

September marks Children’s Cancer Awareness Month, a time to bring awareness of the devastating effects of childhood cancer and raise vital funds for research into finding a cure.
To commemorate, Children’s Cancer Institute has engaged in a variety of awareness and fundraising activities throughout the month.

The post Childhood Cancer Awareness Month appeared first on Children's Cancer Institute.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Olivia Lambert was a bright and happy little girl with an infectious smile and a fun-loving spirit. Diagnosed with stage 4 neuroblastoma at age two and a half, she fought the disease bravely for six years. Her legacy and spirit continue with the appointment of Dr Joshua McCarroll as the Olivia Lambert Team Leader.

The post A little girl’s legacy: Olivia Lambert Team Leader appointed appeared first on Children's Cancer Institute.

Read Full Article

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview